DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...
Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...
AZoLifeSciences on MSN
The Promise and Perils of Reprogramming Immunity
The evolution of immunotherapy, featuring CAR-T cells and senolytics, highlights potential in cancer treatment and challenges ...
Rachael brings a wealth of experience in strategic planning and business development across the biopharmaceutical industry and joins CytomX at a time when our platform and pipeline are well positioned ...
Scale” model spotted a drug combination that made tumors more visible to the immune system, a breakthrough Google calls “a ...
Therapeutics entered into an exclusive licensing agreement with Nanjing Leads Biolabs for DNTH212, a first and potentially ...
In a breakthrough that could potentially rewrite the prevention and treatment of cancer, scientists have discovered how ...
Researchers have identified a rare type of brain cell that may drive the chronic inflammation and neurodegeneration seen in progressive multiple sclerosis (MS).
Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...
Amla and turmeric are both Ayurveda-approved food ingredients that are known for their medicinal properties. While they can ...
That’s because our body doesn’t make enough of the stuff in the darker months as sunlight decreases. Vitamin D is key to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results